HPS Pharmacies wish to advise that Abraxis Bioscience Australia Pty Ltd have given notice of a voluntary drug recall of:
|Abraxane® Powder for Injection|
|Expiry Date||February 2015|
This recall has been issued because routine testing has identified a deviation of sterility at the manufacturing facility. This batch met all product specifications at its release, but was not specifically tested for sterility at that time.
Newer batches of Abraxane® (paclitaxel) 100mg powder for injection are already in circulation, and there is not expected to be any shortage of supply. No other batches of Abraxane® are affected by this recall.
Please inspect your stocks and quarantine all units from the batch specified above for return to your supplier who will arrange for replacement. Any items from this batch supplied by HPS Pharmacies should be returned to the pharmacy for processing.
Retain this notice in a prominent position, including other related business units for one month in case stock is in transit. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please do not hesitate to contact your pharmacist at HPS Pharmacies or Special Therapeutics Australia on 1300 798 820.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.